ClinicalTrials.gov primary vs. study completion date: what each means

01

The two dates close different data-collection windows

ClinicalTrials.gov defines primary completion as the date the final participant was examined or received an intervention for final collection of data for the primary outcome measure. When a study has multiple primary outcomes with different collection dates, the date covers final collection for all primary outcomes. A terminated study can still have a primary completion date.

Study completion is broader: the date the final participant was examined or received an intervention for final collection of primary and secondary outcomes and adverse events. In a trial with long-term safety follow-up, the study completion date can be months or years after primary completion. In another trial, the dates can be the same.

Neither date is the date of enrollment completion, database lock, statistical analysis, press release, journal publication, regulatory submission, or FDA action unless the record or another source explicitly says so. Treat each as a defined data-collection milestone.

02

Estimated and actual are not interchangeable

An estimated date is the responsible party's current forecast. Recruitment pace, protocol changes, event accrual, site operations, follow-up, or an early stop can move it. An actual date indicates the milestone occurred, but it still does not say whether the data were cleaned, analyzed, submitted, or favorable.

Read the overall recruitment status with the date. Active, not recruiting may mean enrollment stopped while participants remain in follow-up. Completed means the study ended normally and participants are no longer being examined or treated for data collection, but completed is not a result. Terminated means the study stopped early after enrollment began; withdrawn means it stopped before any participant enrolled.

Check the Record Verification Date. ClinicalTrials.gov recommends periodic updates, and a date that passed while the record remains unverified may be stale. The site's “Unknown” status can apply when certain recruiting records pass their completion date and have not been verified within the specified period.

03

Why primary completion matters for posted results

ClinicalTrials.gov explains that for applicable clinical trials subject to the results requirements, the standard deadline is generally no later than one year after primary completion. The responsible party—not the registry—is responsible for determining applicability, registering the study, maintaining the record, and submitting required results.

The rules contain details and possible delayed-submission certifications, extensions, waivers, and different obligations. A public reader should not declare a sponsor legally noncompliant merely by adding one year to a displayed date. First confirm that the trial is covered, which date is actual, whether results are required, and whether a certification or other allowed condition applies.

Results Submitted and Results Posted are also different states. Submitted material may be undergoing registry quality-control review and is not necessarily public. Posted tables are public but are not journal peer review or FDA approval. Read participant flow, baseline characteristics, outcomes, adverse events, limitations, and record history.

04

Read outcome timing with the dates

Open the primary and secondary outcome definitions. Record the measure, metric, aggregation method, and time frame. A primary completion date cannot be interpreted without knowing whether the endpoint was measured at 12 weeks, after a fixed number of events, or through a longer observation window.

A sponsor can announce top-line results after primary completion while safety follow-up continues toward study completion. That does not make the remaining follow-up unimportant. Conversely, a study can reach completion without the product meeting its primary endpoint. The date answers when data collection ended, not what the data showed.

For peptide candidates, match the exact molecule, route, formulation, dose arms, indication, population, sponsor, and NCT number. A provider should not cite a completion date for one candidate as proof that another compounded or research product has completed successful trials.

05

Audit the History of Changes

ClinicalTrials.gov provides a History of Changes for study records. Compare the version available when a provider or sponsor made a claim with the current record. Note when estimated dates moved, when status became actual, and whether outcomes, enrollment, arms, eligibility criteria, or sponsor information changed.

A moved date is not automatically misconduct or trial failure. Operational changes and continued follow-up can be legitimate. Ask whether the explanation is documented, whether the protocol or statistical analysis plan changed, and whether the updated timeline affects the claim being evaluated. Avoid accusing an investigator or company without authoritative evidence.

Save the NCT number, version dates, date type, recruitment status, verification date, primary and study completion dates, results status, and relevant publications. This creates a reproducible note instead of a screenshot that loses context.

• →NCT number and exact intervention
• →Estimated or actual date type
• →Recruitment and verification status
• →Primary and secondary outcome time frames
• →History-of-changes comparison
• →Results, publication, and FDA status

06

Timeline claims and warning signs

Question statements such as “Phase 3 completed, so approval is next,” “the trial ended successfully,” or “results are overdue” when the speaker cites only a completion date. Also question a clinic that removes estimated or actual labels, substitutes study completion for primary completion, or presents an NCT record as evidence that a marketed product is approved.

Trial timing is only one evidence layer. Approval requires a product-specific application and FDA action; publication requires separate editorial processes; and clinical meaning depends on the actual results and limitations. A registry entry is submitted by the responsible party and can change as the record is maintained.

Do not use a projected date to make treatment decisions, self-administer an investigational substance, or assume access. An appropriately licensed clinician can discuss lawful trial participation or approved options in the context of an individual's condition.